AAAAAA

   
Results: 1-7 |
Results: 7
Presence of cystic fibrosis-related diabetes mellitus is tightly linked topoor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis
Authors: Koch, C Rainisio, M Madessani, U Harms, HK Hodson, ME Mastella, G McKenzie, SG Navarro, J Strandvik, B
Citation: C. Koch et al., Presence of cystic fibrosis-related diabetes mellitus is tightly linked topoor lung function in patients with cystic fibrosis: Data from the European Epidemiologic Registry of Cystic Fibrosis, PEDIAT PULM, 32(5), 2001, pp. 343-350
European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations
Authors: Koch, C Cuppens, H Rainisio, M Madessani, U Harms, HK Hodson, ME Mastella, G Navarro, J Strandvik, B McKenzie, SG
Citation: C. Koch et al., European Epidemiologic Registry of Cystic Fibrosis (ERCF): Comparison of major disease manifestations between patients with different classes of mutations, PEDIAT PULM, 31(1), 2001, pp. 1-12
Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF
Authors: Navarro, J Rainisio, M Harms, HK Hodson, ME Koch, C Mastella, G Strandvik, B McKenzie, SG
Citation: J. Navarro et al., Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF, EUR RESP J, 18(2), 2001, pp. 298-305
Allergic bronchopulmonary aspergillosis in cystic fibrosis
Authors: Mastella, G Rainisio, M Harms, HK Hodson, ME Koch, C Navarro, J Strandvik, B McKenzie, SG
Citation: G. Mastella et al., Allergic bronchopulmonary aspergillosis in cystic fibrosis, EUR RESP J, 17(5), 2001, pp. 1052-1053
Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study
Authors: Channick, RN Simonneau, G Sitbon, O Robbins, IM Frost, A Tapson, VF Badesch, DB Roux, S Rainisio, M Bodin, F Rubin, LJ
Citation: Rn. Channick et al., Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study, LANCET, 358(9288), 2001, pp. 1119-1123
A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period
Authors: Shah, PL Conway, S Scott, SF Rainisio, M Wildman, M Stableforth, D Hodson, ME
Citation: Pl. Shah et al., A case-controlled study with dornase alfa to evaluate impact on disease progression over a 4-year period, RESPIRATION, 68(2), 2001, pp. 160-164
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study
Authors: Mastella, G Rainisio, M Harms, HK Hodson, ME Koch, C Navarro, J Strandvik, B McKenzie, SG
Citation: G. Mastella et al., Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study, EUR RESP J, 16(3), 2000, pp. 464-471
Risultati: 1-7 |